Literature DB >> 25004300

Adenocarcinoma of transposed colon: first case of synchronous tumor.

Rubens Antonio Aissar Sallum1, Gilton Marques Fonseca1, Sergio Szachnowicz1, Francisco Carlos Bernal da Costa Seguro1, Ivan Cecconello1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25004300      PMCID: PMC4678685          DOI: 10.1590/s0102-67202014000200018

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


× No keyword cloud information.

INTRODUCTION

The surgical and anatomical basis for using the colon as a substitute for the esophagus were established in 1911 by Kelling and Vuillet[1] and for many years was the technique of choice for esophageal replacement[2]. Its use is helpful in benign diseases, such as caustic or peptic strictures, and malignancies[1,3], especially when the stomach cannot be used, and also in children with congenital anomalies[2,4]. However, this procedure is subject to early complications, as ischemia of the colon and leakage[5], or late problems as anastomosis stenosis, ischemic colitis, fistula due to diverticulitis and malignant lesions[4]. The transposed colon cancer is a rare complication. Since 2007, six new cases were reported and two reviews published. Hwang et al[6] found 10 reported cases of adenocarcinoma in the transposed colon and Bando et al[7] also reviewed 10 cases in the literature, encompassing adenomas and adenocarcinomas. The aim is to report an unique case of synchronous adenocarcinoma of the transposed colon.

CASE REPORT

Woman with 53-years-old diagnosed with congenital esophageal atresia, underwent to several surgical procedures in childhood, the latest was a cervical retrosternal esophagocoloplasty at 11 years old. After 42 years she was evolved with cervical dysphagia, and an initial diagnosis of stenosis of the esophagocolic anastomosis was performed, treated with endoscopic dilation without improvement. Later, biopsies were performed in the area of ​​stenosis in proximal colonic segment (Figure 1) and polypectomy of sessile polyp of 10 mm, 5 cm distal to the stenosis (Figure 2). The pathological assessment showed tubular-villous intramucosal adenocarcinoma at the resected polyp and the area of ​​stenosis was a invasive adenocarcinoma in colonic mucosa. Colonoscopy of remained colon was normal. Staging performed with CT scan showed an eccentric wall thickening of proximal colon transposed with luminal reduction target of left innominate vein; densification of mediastinal fat plane adjacent and regional lymph nodes up to 1.9 cm.
Figure 1

Endoscopic view of the stenotic area in proximal colonic segment with advanced adenocarcinoma

Figure 2

Endoscopic view of the sessile polyp with sincronous intramucosal adenocarcinoma at the transposed colon more distal

Endoscopic view of the stenotic area in proximal colonic segment with advanced adenocarcinoma Endoscopic view of the sessile polyp with sincronous intramucosal adenocarcinoma at the transposed colon more distal Surgical treatment was performed with neck incision, sternotomy and laparotomy with resection of the colon transposed and a tactic transhiatal esophagectomy of the atresic esophagus in order to pull up the greater curvature gastric conduit obtained by the posterior mediastinum route. Resection of a portion of the left innominate vein which was invaded by the tumor was also performed. The pathological examination of surgical specimen showed moderately differentiated tubular adenocarcinoma invading pericolical tissues and the left innominate vein, with no affected lymph nodes - p T4 N0 (0 / 42) M0. The patient developed postoperative superior vena cava syndrome, treated by anticoagulation. She had ischemia of the proximal portion of the stomach transposed being performed partial gastrectomy, and respiratory complications. She remained in intensive care and under multidisciplinary clinical support. Discharge of the hospital was after 128 days. Patient developed recurrent disease (lung metastases), started chemotherapy, and died nine months after surgery due to pneumonia.

DISCUSSION

There are basically three options for replacement after esophageal resection: stomach, colon and small bowel[8]. For many years, the colon was considered the organ of choice, but the stomach has been the most widely used in recent decades due facility of preparation of the gastric conduit and its more robust vascular supply as a result of a rich submucosal vascular layer[9]. Resection of the gastric lesser curvature allows elongation and a safe cervical anastomosis[8,10,11]. In cases of previous gastrectomy, gastric caustic or peptic strictures, tumor involvement of the stomach or failed gastroplasty the colon is used[9]. Colonic interposition may have early complications as transposed colon ischemia and anastomotic fistula. Late complications as anastomotic stricture "redundant graft", ulceration, colitis, perforation, diverticulitis, or tumor in the colonic segment are reported[4,5]. Must be remembered that colorectal cancer has a high incidence; is the third leading cause of cancer diagnosed in men and second among women in the world[12] and this colonic segment has a risk for malignancy too. There are 21 cases of adenoma/adenocarcinoma in transposed colon described in literature[1,3-7]. This case shows that all patient underwent to esophagocoloplasty and develops dysphagia during late follow-up should be investigated for malignancy and the initial diagnosis of stenosis of the esophagocolic anastomosis without biopsy should be evoid.
  12 in total

1.  Esophageal reconstruction for benign disease: early morbidity, mortality, and functional results.

Authors:  M M Young; C Deschamps; V F Trastek; M S Allen; D L Miller; C D Schleck; P C Pairolero
Journal:  Ann Thorac Surg       Date:  2000-11       Impact factor: 4.330

2.  A case of more abundant and dysplastic adenomas in the interposed colon than in the native colon.

Authors:  Hye Jin Hwang; Kyung Ho Song; Young Hoon Youn; Ji Eun Kwon; Hoguen Kim; Jae Bock Chung; Yong Chan Lee
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

3.  Operative outcome of colon interposition in the treatment of esophageal cancer: a 20-year experience.

Authors:  Christian Daniel Klink; Marcel Binnebösel; Mark Schneider; Kerstin Ophoff; Volker Schumpelick; Mark Jansen
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

Review 4.  A laterally-spreading tumor in a colonic interposition treated by endoscopic submucosal dissection.

Authors:  Hideaki Bando; Hiroaki Ikematsu; Kuang-I Fu; Yasuhiro Oono; Takashi Kojima; Keiko Minashi; Tomonori Yano; Takahisa Matsuda; Yutaka Saito; Kazuhiro Kaneko; Atsushi Ohtsu
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

5.  Colon interposition after esophagectomy with extended lymphadenectomy for esophageal cancer.

Authors:  Shinji Mine; Harushi Udagawa; Kenji Tsutsumi; Yoshihiro Kinoshita; Masaki Ueno; Kazuhisa Ehara; Syusuke Haruta
Journal:  Ann Thorac Surg       Date:  2009-11       Impact factor: 4.330

Review 6.  Malignant tumor developed in colon-esophagus.

Authors:  A Altorjay; J Kiss; A Vörös; I Szanto; A Bohak
Journal:  Hepatogastroenterology       Date:  1995 Nov-Dec

7.  Dukes A carcinoma after colonic interposition for oesophageal stricture.

Authors:  A D Houghton; M Jourdan; I McColl
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

8.  Metastatic adenocarcinoma from oesophageal colonic interposition.

Authors:  A A Licata; P Fecanin; R Glowitz
Journal:  Lancet       Date:  1978-02-04       Impact factor: 79.321

9.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

10.  Colonic interposition after esophagectomy for cancer.

Authors:  Peter A Davis; Simon Law; John Wong
Journal:  Arch Surg       Date:  2003-03
View more
  1 in total

1.  Squamous cell carcinoma (SCC) arising in esophageal colon interposition.

Authors:  Reza Taslimi; Akram Jowkar; Mohammad Reza Hasani Ghavam; Tayebeh Tavasol; Seyed Farshad Allameh; Naser Rakhshani
Journal:  Oxf Med Case Reports       Date:  2017-12-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.